康沣生物科技（上海）股份有限公司（简称“康沣生物-B”，股票代码：06922）于2026年3月4日披露截至2026年2月28日的证券变动月报。报告期内，公司已发行H股数量为149,033,579股，非上市股份数量为95,671,421股，上述股数与上月末持平。
本月未出现新增发行、回购、注销或库存股变动，注册股本总额继续维持在244,705,000元人民币。公告同时显示，公司确认其H股部分符合香港联合交易所有限公司相关公众持股量要求。
本次月报由公司董事朱军签署。公司表示，将持续遵守香港联交所《上市规则》及相关法律法规。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.